Navigation Links
Ambit Biosciences Strengthens Board of Directors and Executive Team
Date:11/8/2010

SAN DIEGO, Nov. 8, 2010 /PRNewswire/ -- Ambit Biosciences Corporation (Ambit) today announced the strengthening of its Board and management team.  

"The Board is delighted to appoint biotechnology industry veteran Faheem Hasnain as Chairman of the Board and to strengthen the executive management team with the appointment of Alan Fuhrman as Chief Financial Officer and the promotion of Christopher Morl to Chief Operating Officer," said Alan Lewis, President and Chief Executive Officer of Ambit.

Mr. Hasnain has built a distinguished career within the realm of oncology.  From December 2008 until its acquisition by Abbott Laboratories in April 2010, he was the president and chief executive officer and a director of Facet Biotech Corporation, a biology-driven antibody company with a focus in oncology and multiple sclerosis. Mr. Hasnain was president, chief executive officer and a director of PDL BioPharma, Inc. from October 2008 until Facet Biotech was spun off from PDL BioPharma in December 2008. From October 2004 to September 2008, Mr. Hasnain served at Biogen Idec Inc., a biotechnology company specializing in neurological disorders, autoimmune disorders and cancer, most recently as executive vice president in charge of the oncology/rheumatology strategic business unit. Prior to Biogen Idec, Mr. Hasnain held roles with Bristol-Myers Squibb, where he was president of the Oncology Therapeutics Network, and for 14 years at GlaxoSmithKline and its predecessor organizations. Mr. Hasnain has served on the board of directors of Somaxon Pharmaceuticals since September 2010.  Mr. Hasnain received a B.H.K. and B.Ed. from the University of Windsor Ontario in Canada.

Alan Fuhrman joins Ambit as Chief Financial Officer.  From November 2008 to September 2010, Mr. Fuhrman served as vice president and chief financial officer of Naviscan, Inc., a medical imaging company focused on the management of breast cancer. From September 2004 th
'/>"/>

SOURCE Ambit Biosciences Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference
2. Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications
3. Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting
4. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
7. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
8. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
9. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
10. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
11. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... July 11, 2014 Neurelis, Inc. ("Neurelis") today ... end the option held by Biotie to purchase Neurelis, ... of NRL-1 (intranasal diazepam) for pediatric and adult epilepsy ... the past year, Biotie has advanced the development program ... the pivotal clinical work required for NDA submission to ...
(Date:7/10/2014)... , 11. Juli 2014 /PRNewswire/ ... Kameras für die molekulare Bildgebung, einschließlich ... heute die CE-Zulassung für sein Navigator ... kann Dilon das Produkt jetzt europaweit ... den Großteil der europäischen Länder ausgedehnt ...
(Date:7/10/2014)...  Breg, Inc., a premier provider of sports ... knee brace with new innovations to help people, ... to active lifestyles.  FreeRunner,s patent-pending design acts on ... when patients need it most, and the ability ... Patellofemoral issues are the most common cause of ...
Breaking Medicine Technology:Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2
... The Prix Galien USA committee recognized excellence in scientific ... during the fifth annual Prix Galien Awards Gala. The Pro ... for best biotechnology product and best pharmaceutical agent were presented ... in New York City.   The Prix Galien ...
... AdvaMed 2011: The MedTech Conference ... exhibitors including Abbott, Abiomed, B. Braun Medical, Baxter ... KCI, and MIT MEDRC in Innovation Alley, a ... technologies. Three sector meet-ups focused on orthopedic, wound ...
Cached Medicine Technology:Excellence in Scientific Innovation and Humanitarian Efforts Honored at 2011 Prix Galien Award Ceremony 2AdvaMed 2011: The MedTech Conference Closing Day Features Life Changing Innovation, Policymaker Addresses 2
(Date:7/12/2014)... Angeles, CA (PRWEB) July 12, 2014 ... buyer power score of 4.1 out of 5. ... market that have been underpinning buyer negotiation power ... IBISWorld procurement analyst Anna Son, “during the period, ... with rising costs associated with new product development, ...
(Date:7/11/2014)... 12, 2014 Recently, MagicQuinceaneraDresses.com, the popular ... new collection of 2014 Quinceanera dresses . The ... want to look fashionable without paying a large amount ... up to 57% off. , The company’s online shop ... get amazing special occasion outfits. In addition to exquisite ...
(Date:7/11/2014)... 11, 2014 Ticket Down reports that tickets ... and 3rd place World Cup Match between Brazil and ... will take place on Saturday, July 12th at Estadio Nacional ... Finals will take place on Sunday, July 13th at Estadio ... All tickets for the 2014 World Cup are guaranteed to ...
(Date:7/11/2014)... -- People with the lowest incomes may have a higher ... a new study suggests. People with PAD have narrowing ... often the legs. The condition causes leg pain and is ... body. People with PAD have a higher risk for heart ... people with PAD who took part in the U.S. National ...
(Date:7/11/2014)... 2014 As part of its ... LLP has been closely monitoring the ongoing meeting ... Obstetrics and Gynecology Devices Panel, which has ... cancer risks associated with the use of power ... a report published by Dow Jones Business News, ...
Breaking Medicine News(10 mins):Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Cheap Quinceanera Dresses Now Available At MagicQuinceaneraDresses.com 2Health News:Argentina vs. Germany World Cup Finals Tickets & Brazil vs. Netherlands 3rd Place World Cup Tickets Are in Huge Demand 2Health News:Poor More Prone to Leg Circulation Trouble 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 4
... So what do you get for the nut,that has ... the Ask Doctor Chuck talking therapy doll?, You can ... by providing,someone who needs it, their own personal and portable ... kook in line, which could,earn you the undying gratitude of ...
... Higher-risk Myelodysplastic Syndromes (MDS), Thalidomide in Multiple ... ... Pharmion Corporation,(Nasdaq: PHRM ) reported today that data from ... will,be presented at the American Society of Hematology,s (ASH) 49th Annual,Meeting ...
... Dec. 6 Arete Therapeutics Inc., a,privately-held biopharmaceutical ... of cardiovascular, inflammatory and,metabolic diseases, today announced the ... directors., "We are very pleased to welcome ... and operational insights will be of great benefit ...
... More in ... 2008, - Late-Stage Pipeline Offers Promising Outlook; 6 Launches Expected by end ... of 2011, ... in Unprecedented 44 New Molecules Under Development, - Transformation Efforts to Focus ...
... StemCor Systems, Inc., a,medical device company developing ... it has acquired U.S. Patent 6,849,051,"Devices And ... associated,know-how from USPure Sciences, LLC. The patent ... from bone cavities. The concept and,technologies are ...
... EpiCept Corporation,(Nasdaq and OMX Nordic Exchange: EPCT) today ... a company overview at the New York Society,of ... Pharma,Conference on December 12, 2007 at 4:05 p.m. ... NYSSA,s headquarters at 1177 Avenue of the Americas ...
Cached Medicine News:Health News:The Cure for Holiday Stress 2Health News:Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology (ASH) Annual Meeting 2Health News:Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology (ASH) Annual Meeting 3Health News:Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology (ASH) Annual Meeting 4Health News:Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology (ASH) Annual Meeting 5Health News:Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology (ASH) Annual Meeting 6Health News:Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology (ASH) Annual Meeting 7Health News:Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology (ASH) Annual Meeting 8Health News:Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology (ASH) Annual Meeting 9Health News:Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology (ASH) Annual Meeting 10Health News:Arete Therapeutics Appoints Donald Santel to Board of Directors 2Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 2Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 3Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 4Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 5Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 6Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 7Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 8Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 9Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 10Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 11Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 12Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 13Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 14Health News:StemCor Systems Announces Acquisition of Intellectual Property to Enhance Bone Marrow Aspiration Platform 2Health News:StemCor Systems Announces Acquisition of Intellectual Property to Enhance Bone Marrow Aspiration Platform 3Health News:EpiCept Corporation to Present at The New York Society of Security Analysts 11th Annual Biotech & Specialty Pharma Conference 2Health News:EpiCept Corporation to Present at The New York Society of Security Analysts 11th Annual Biotech & Specialty Pharma Conference 3
Hydrodissection / Aspiration Cannula, 25 g. Angled with right hook. 10 mm angled shaft with 2.5 mm right hook tip. Overall length 20 mm. 5/box....
Posterior Capsule Polisher, 23 g., 30 angle small gauge with roughened tip, open end port. Overall length 16 mm. 5/box....
Irrigating Cystotome, formed, 27 g., short 8 mm curved tip. Overall length 14 mm. 5/box....
Peribulbar Needle, 23 g. Atkinson style bevel. Overall length 31 mm. 5/box....
Medicine Products: